SCHEMBL6124236

SCHEMBL6124236

CC(=O)N1CCc2nc(C(C)C)ccc21

nearest known ligand 0.44

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 11/20 0.44
CYP2C9 P11712 2/20 0.43
CYP2D6 P10635 1/20 0.43
IDO1 P14902 7/20 0.43
KCNH2 Q12809 5/20 0.43
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22158281 0.88 IDO1 (0.43) CYP2C9IDO1KCNH2CYP3A4
SCHEMBL6124247 0.84 IDO1 (0.43) CYP2C9IDO1KCNH2CYP11B1CYP11B2
SCHEMBL7941087 0.80 NOTUM (0.51) NOTUMCYP11B1CYP11B2
SCHEMBL6124262 0.76 IDO1 (0.49) CYP2C9IDO1KCNH2CYP3A4
SCHEMBL6124268 0.76 IDO1 (0.34) CYP2C9IDO1KCNH2CYP3A4
SCHEMBL6124234 0.73 CYP11B1 (0.39) IDO1KCNH2CYP11B1CYP11B2
SCHEMBL15632547 0.70 NOTUM (0.56) NOTUMCYP2C9CYP2D6CYP11B1CYP11B2
Hydrochloric Acid SCHEMBL15648804 0.69 NOTUM (0.54) NOTUMCYP2C9CYP2D6CYP11B1CYP11B2
SCHEMBL22397636 0.69 IDO1 (0.47) CYP2C9IDO1KCNH2CYP3A4
SCHEMBL6124253 0.68 NOTUM (0.65) NOTUMCYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809318-B2 Gamma secretase modulators MERCK SHARP & DOHME CORP. (US) 2014-08-19 US disclosed
US-8487099-B2 Gamma secretase modulators MERCK SHARP & DOHME CORP. (US) 2013-07-16 US disclosed
US-20120129846-A1 GAMMA SECRETASE MODULATORS Merck, Sharp & Dohme, Corp. 2012-05-24 US disclosed
US-20120107328-A1 GAMMA SECRETASE MODULATORS MERCK SHARP & DOHME CORP. 2012-05-03 US disclosed
US-20120107328-A1 GAMMA SECRETASE MODULATORS MERCK SHARP & DOHME CORP. 2012-05-03 US disclosed
US-20110306593-A1 GAMMA SECRETASE MODULATORS MERCK SHARP & DOHME LLC 2011-12-15 US disclosed
US-20110263529-A1 GAMMA SECRETASE MODULATORS MERCK SHARP & DOHME CORP. 2011-10-27 US disclosed
US-20110263529-A1 GAMMA SECRETASE MODULATORS MERCK SHARP & DOHME CORP. 2011-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120107328-A1 GAMMA SECRETASE MODULATORS BACE1, BACE2, PSEN1 NOTUM 753/4885CYP2C9 4486/4885CYP2D6 4319/4885
US-20120129846-A1 GAMMA SECRETASE MODULATORS BACE1, BACE2, PSEN1 NOTUM 1224/4885CYP2C9 4388/4885CYP2D6 4249/4885
US-20110306593-A1 GAMMA SECRETASE MODULATORS BACE1, BACE2, PSEN1 NOTUM 776/4885CYP2C9 3849/4885CYP2D6 4119/4885
US-20110263529-A1 GAMMA SECRETASE MODULATORS BACE1, BACE2, PSEN1 NOTUM 1308/4885CYP2C9 4650/4885CYP2D6 4579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.